Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This approval make the treatment of nGBM and rGBM with DCVax-L available to the US with the right to import the tumor and export the vaccine from the UK. Does it Not?
Let me help you, the MTD are just Desperate Pleas filed by desperate people with no moral compass to guide them.
The events that took place on 5/10/22 made MWBO change their strategy.
10.7% VS 0% Survival rate at 5 Years is a phenomenal difference. First trial in 30 years to move the needle for rGBM! So if your a scientist and more importantly a doctor, how do you justify not approving DCVax-L? Answer- You approve it. End of subject. That's in the near future.
To quote Al Musella" To put it in perspective, for newly diagnosed glioblastoma, of the 1,366 patients in the control group none survived 5 years and of these 232 patients who got devax, 25 were alive at 5 years. This is for an easy treatment with no side effects. No nausea, hair loss".
You can bullshit all you want. But 25 Beating hearts after 5 years out of 232 speaks volumes. That is the "Fat Tail" that we continually reference. IT IS AN AMAZING BREAKTHROUGH!
It will take 100 years for approval will be the narrative. The fudsters have nothing. DCVax -L will be approved by all 4 RA's despite the 7 market makers efforts.
Yes, I could have made that clearer. Thanks Flipper.
Despite insiders selling off and other analysts downgrading, Motley is recommending. Hmmmmmm.
Despite insiders selling off and other analysts downgrading, Motley is recommending. Hmmmmmm.
If I was them I would buy back stock creating a short squeeze at the same time of approval.
Never settle for less than 1/10 of what you lost. They have the evidence and the jury will be punitive considering the circumstances. Considering the The 7 Market Makers ;
1 Canaccord Genuity LLC,
2 Citadel Securities LLC
3 G1 Execution Services LLC,
4 GTS Securities LLC,
5 Instinet LLC, Lime Trading Corp. a Nomura company
6 Susquehanna International Group LLP,
7 Virtu Americas LLC Ten Billion is chump change.
And then the SAP analysis.
your wrong. Data Lock was not 3 Years ago.
Your sources apparently are not keeping you up to date.
Add- Reinforcing Journal article with over 70 coauthors.
Don't blame Linda for the manipulation efforts of others. The 7 Market Makers ;
1 Canaccord Genuity LLC,
2 Citadel Securities LLC
3 G1 Execution Services LLC,
4 GTS Securities LLC,
5 Instinet LLC, Lime Trading Corp. a Nomura company
6 Susquehanna International Group LLP,
7 Virtu Americas LLC
Are to blame for prolonging DCVax's approval process. Make no mistake about it, without the "Manipulative 7" a Journal article would not have been necessary. Without them countless patients would be utilizing this treatment and it would be saving and extending lives.
GRIP, If this stock is a Dog, why are you posting all this negative BS 24/7? To save us longs? Save yourself, forget us longs.
I Wonder how many Spoofing Episodes they did the morning of 3/15/23? Total BS.
I must admit on 5/10/22 I was surprised when the price started to fall prior to the news being delivered. Up until that date, I was aware of claims of manipulation but I certainly didn't understand what the MM were capable of. On that day, LP did pivot and I believe changed her game plan which is still unfolding.
If you don't believe in the product or the CEO why would you ever invest in a company? Eventually, DCVax-L will be approved by all 4 RA's and it will be a direct result of LL and LP efforts.
We will see soon, who was the fool. All longs trust LL and LP implicitly as both are inspiring.
It's called control. LP is not going to let any one company or country stop her.
The key here Hydro is they did not unblind until the SAP was issued. completely acceptable.
The 7 Market Makers ;
1 Canaccord Genuity LLC,
2 Citadel Securities LLC
3 G1 Execution Services LLC,
4 GTS Securities LLC,
5 Instinet LLC, Lime Trading Corp. a Nomura company
6 Susquehanna International Group LLP,
7 Virtu Americas LLC
Are to blame for prolonging DCVax's approval process. Make no mistake about it, without the "Manipulative 7" a Journal article would not have been necessary. Without them countless patients would be utilizing this treatment and it would be saving and extending lives.
They don't have a treatment that is the First Trial to move the needle in rGBM in 30 YEARS! After 2,000 plus failures.
Because if he does go into detail, he is gonna loose.
I was thinking the same thing. Total BS the fines probably don't even cover the cost.
How many civil litigations?
The odds are with you if you don't have any moral ethics.
If you think St. Peter is going to let you through the pearly gates because you donated a bike path but you tried to nix a cure for cancer, think again.
His posts after all these months indicate Hygro does not want to know anything about the results of the trial.
Thermo - "Of course, some longs sold; it was just too tempting."
On 5/10/22 longs did sell. They were not big longs, but retired longs that could not afford to take the hit.
The 7 MM chose to show their gorilla strength. Not thinking of course that this is a cure for rGBM. Total Idiots.
That is only because DCVax-L has not been approved. If it was, I am confident he would choose a combination therapy with DCVax-L and a check point inhibitor.
Al Muselia can only recommend what is Approved.
Only to eliminate crazy conspiracy theories authored by the shorts.
The Company did inform the share holders. NWBO filed a Lawsuit against
7 Market Makers. Didn't you read about it?
IMO these shares will be purchased by a partner. How many have they sold?
Upon approval we will be back in the 2.15 range or better what's your point?
If they didn't issue the PR the shorts would have NWBO financing SVB.
I didn't say RG?
The RA will evaluate the phase 3 trial results for DCVax for both safety & efficacy. DCVax safety record is excellent and this is the first rGBM trial to indicate progress in 30 years. If the FDA don't approve DCVax the other 3 RA's will. That is not going to happen. With the tremendous results, all 4 RA's will approve it.